Toronto Dominion Bank Jazz Pharmaceuticals PLC Transaction History

Toronto Dominion Bank

  • $55.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$115.19 - $132.77 $240,862 - $277,622
-2,091 Reduced 21.84%
7,482 $900,000
Q4 2023

Feb 13, 2024
SELL
$114.26 - $136.0 $506,400 - $602,752
-4,432 Reduced 31.65%
9,573 $1.18 Million
Q3 2023

Feb 14, 2024
BUY
$122.0 - $145.31 $540,704 - $644,013
4,432 Added 46.3%
14,005 $1.81 Million
Q3 2023

Nov 14, 2023
BUY
$122.0 - $145.31 $1.71 Million - $2.04 Million
14,005 New
14,005 $1.81 Million

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email